Description: Ortin Laboratories Limited manufactures and sells pharmaceuticals, drugs, and intermediates in India. The company offers various pharmaceutical formulations of tablets, capsules, syrups, and dry powders. It provides formulations, such as anti diabetics, anti allergics, sedatives and tranquilisers, anti helmenthetics, analgesics and antipyretics, anti biotics-quinolones, anti biotic-pencillins, cephalosporins, and macrolides; and anti anginal and cardio vascular, and antifungal products. The company's formulations also include chemo therapeutics, antacids and anti ulcerants, anti spasmodics, calcium preparations, iron preparations, anti arthritic drugs, protein supplements, enzymes, and vitamins, as well as psychiatry, appetizer, gynaec, and anti retroviral products. In addition, it provides active pharmaceutical ingredient (API) intermediates comprising anti retro virals, anti diabetics, analgesics and antipyretics, anti biotics, antifungals, antacids and anti ulcerants, and anti malarials; and manufactures fine chemicals, and grignard and alkali metal products. Further, the company offers services in the areas of process development, process characterization, analytical research and development, assay development, and product characterization; and diagnostic services, including development of rapid flow kits, assays, and reagents. Additionally, it undertakes long-term contracts for manufacturing intermediates and developing new APIs; and operates as a merchant exporter of pharmaceutical finished formulations. Ortin Laboratories Limited was founded in 1986 and is based in Hyderabad, India.
Home Page: www.ortinlabsindia.com
Officers
| Name | Title |
|---|---|
| Mr. Sanka Murali Krishna Murthy | Chairman, CEO & MD |
| Mr. Gaddam Venkata Ramana | Joint MD & Director |
| Mr. Satyanarayana Raju Bhupathiraju | CFO, Director of Fin. & Whole Time Director |
| Mr. Sanka Balaji Venkateswarlu | Director of Marketing & Non-Exec. Director |
| Mr. Sanka Srinivasa Kumar | Director of Marketing & Whole Time Director |
Exchange: BSE
Country: IN
Currency: Indian Rupee (INR)
| Forward PE: | 0 |
|---|---|
| Trailing PE: | 0 |
| Price-to-Book MRQ: | 2.0078 |
| Price-to-Sales TTM: | 0.1886 |
| IPO Date: | |
| Fiscal Year End: | March |
| Full Time Employees: | 0 |